BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced the launch of Nebivolol Tablets, 2.5 mg, 5 mg, 10 mg, and 20 mg. ANI’s Nebivolol ...
Nebivolol tablets have a market value of roughly $978 million for the 12 months ending October 2021, according to IQVIA. Aurobindo has received The Food and Drug Administration’s blessing for ...